Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	LDE225 (Sonidegib) 200 mg	79
Overall Study	STARTED	LDE225 (Sonidegib) 800 mg	151
Overall Study	Untreated	LDE225 (Sonidegib) 200 mg	0
Overall Study	Untreated	LDE225 (Sonidegib) 800 mg	1
Overall Study	Patients Cont. to Next Phase of Trial	LDE225 (Sonidegib) 200 mg	52
Overall Study	Patients Cont. to Next Phase of Trial	LDE225 (Sonidegib) 800 mg	89
Overall Study	Survival Follow-up	LDE225 (Sonidegib) 200 mg	33
Overall Study	Survival Follow-up	LDE225 (Sonidegib) 800 mg	49
Overall Study	Post-treatment Follow-up	LDE225 (Sonidegib) 200 mg	19
Overall Study	Post-treatment Follow-up	LDE225 (Sonidegib) 800 mg	40
Overall Study	COMPLETED	LDE225 (Sonidegib) 200 mg	0
Overall Study	COMPLETED	LDE225 (Sonidegib) 800 mg	0
Overall Study	NOT COMPLETED	LDE225 (Sonidegib) 200 mg	79
Overall Study	NOT COMPLETED	LDE225 (Sonidegib) 800 mg	151

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01327053/flow